CircRNAs and cancer: Biomarkers and master regulators

被引:312
|
作者
Arnaiz, Esther [1 ]
Sole, Carla [1 ]
Manterola, Lorea [1 ]
Iparraguirre, Leire [2 ]
Otaegui, David [2 ]
Lawrie, Charles H. [1 ,3 ,4 ]
机构
[1] Biodonostia Res Inst, Mol Oncol Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[2] Biodonostia Res Inst, Multiple Sclerosis Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[3] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England
[4] Ikerbasque, Basque Fdn Sci, Maria Diaz Haroko Kalea 3, Bilbao 48013, Spain
关键词
circRNA; Biomarkers; Liquid biopsies; Non-coding RNA; CIRCULAR RNA EXPRESSION; COLORECTAL-CANCER; GASTRIC-CANCER; CELL-PROLIFERATION; LUNG-CANCER; REVEALS; GENE; TRANSCRIPTS; BIOGENESIS; MIGRATION;
D O I
10.1016/j.semcancer.2018.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circular RNAs (circRNAs) are a novel class of regulatory RNAs that despite being relatively abundant have only recently begun to be explored. There are many thousands of genes that appear capable of producing circRNAs, however the function of all but a handful remain to be determined. What is emerging about these highly conserved molecules is that they play important roles in biology and cancer biology in particular. The most explored function of circRNAs is as master regulators of gene expression that act to sequester or 'sponge' other gene expression regulators, in particular miRNAs. They have also been demonstrated to function via direct modulation of transcription, and by interfering with splicing mechanisms. Although generally expressed in low abundance when compared to their linear counterparts, they are often expressed in a tissue- and developmental stage-specific manner. Coupled with their remarkable resistance to RNAse activity due to a covalent closed cyclic structure, circRNAs show great promise as novel biomarkers of cancer and other diseases. In this review we consider the current state of knowledge regarding these molecules, their synthesis, function, and association with cancer. We will also review some of the challenges that remain to be resolved if this emerging class of RNAs are really to become useful in the clinic.
引用
收藏
页码:90 / 99
页数:10
相关论文
共 50 条
  • [41] Orphan noncoding RNAs: novel regulators and cancer biomarkers
    Teng, Mona
    Liu, Lydia Y.
    Hua, Junjie Tony
    Chen, Sujun
    He, Housheng Hansen
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [42] CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer
    Xu, Yuting
    Xu, Xinwei
    Ocansey, Dickson Kofi Wiredu
    Cao, Hua
    Qiu, Wei
    Tu, Qiang
    Mao, Fei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (03): : 1580 - 1593
  • [43] CircRNAs: A new perspective of biomarkers in the nervous system
    Ma, Yun
    Liu, Yixuan
    Jiang, Zhisheng
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 128
  • [44] YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
    Stefano Piccolo
    Tito Panciera
    Paolo Contessotto
    Michelangelo Cordenonsi
    Nature Cancer, 2023, 4 : 9 - 26
  • [45] A novel gene regulatory network model identifies master regulators in cancer
    Sudalagunta, Praneeth Reddy
    Canevarolo, Rafael Renatino
    Meads, Mark
    Silva, Maria Coelho
    Zhao, Xiaohong
    Alugubelli, Raghunandan Reddy
    Song, Joon-Hyun
    Persi, Erez
    Damaghi, Mehdi
    Shain, Kenneth H.
    Silva, Ariosto
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Master regulators of FGFR2 signalling and breast cancer risk
    Fletcher, Michael N. C.
    Castro, Mauro A. A.
    Wang, Xin
    de Santiago, Ines
    O'Reilly, Martin
    Chin, Suet-Feung
    Rueda, Oscar M.
    Caldas, Carlos
    Ponder, Bruce A. J.
    Markowetz, Florian
    Meyer, Kerstin B.
    NATURE COMMUNICATIONS, 2013, 4
  • [47] Master regulators of FGFR2 signalling and breast cancer risk
    Michael N. C. Fletcher
    Mauro A. A. Castro
    Xin Wang
    Ines de Santiago
    Martin O’Reilly
    Suet-Feung Chin
    Oscar M. Rueda
    Carlos Caldas
    Bruce A. J. Ponder
    Florian Markowetz
    Kerstin B. Meyer
    Nature Communications, 4
  • [48] Pancancer network analysis reveals key master regulators for cancer invasiveness
    Jethalia, Mahesh
    Jani, Siddhi P.
    Ceccarelli, Michele
    Mall, Raghvendra
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [49] The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
    Lasorella, Anna
    Benezra, Robert
    Iavarone, Antonio
    NATURE REVIEWS CANCER, 2014, 14 (02) : 77 - 91
  • [50] Pancancer network analysis reveals key master regulators for cancer invasiveness
    Mahesh Jethalia
    Siddhi P. Jani
    Michele Ceccarelli
    Raghvendra Mall
    Journal of Translational Medicine, 21